Paraoxonase-1, activity in patients with hyperemesis gravidarum

Redox Report

Volumn 13, Issue 3, 2008, Pages 134-138

  Verit, Fatma Ferda ^a   Erel, Ozcan ^a   Celik, Hakim ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

High sensitive C reactive protein; Hyperemesis gravidarum; Oxidative stress; Paraoxonase 1; PON 1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; HYPEREMESIS GRAVIDARUM; INFLAMMATION; OXIDATIVE STRESS; PATHOGENESIS; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPECTROPHOTOMETRY;

ADULT; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYPEREMESIS GRAVIDARUM; LIPID PEROXIDATION; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; PREGNANCY; PREGNANCY COMPLICATIONS; REGRESSION ANALYSIS;

EID: 48749108483     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100008X259259     Document Type: Article

References (34)

1. Broussard CN, Richter JE. Nausea and vomiting of pregnancy. Gastroenterol Clin North Am 1998; 27: 123-47.
2. Agarwal A, Gupta S, Sikka S. The role of free radicals and antioxidants in reproduction. Curr Opin Obstet Gynecol 2006; 18: 325-32.
3. Fait V, Sela S, Ophir E et al. Hyperemesis gravidarum is associated with oxidative stress. Am J Perinatol 2002; 19: 93-8.
4. Güney M, Oral B, Mungan T. Serum lipid peroxidation and antioxidant potential levels in hyperemesis gravidarum. Am J Perinatol 2007; 24: 283-9.
5. van Stuijvenberg ME, Schabort I, Labadarios D, Nel JT. The nutritional status and treatment of patients with hyperemesis gravidarum. Am J Obstet Gynecol 1995; 172: 1585-91.
6. Chiossi G, Neri I, Cavazzuti M, Basso G, Facchinetti F. Hyperemesis gravidarum complicated by Wernicke encephalopathy: Background, case report, and review of the literature. Obstet Gynecol Surv 2006; 61: 255-68.
7. Robinson JN, Anerjee R, Thiet MP. Coagulopathy secondary to vitamin K deficiency in hyperemesis gravidarum. Obstet Gynecol 1998; 92: 673-5.
8. Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 2006; 13: 129-42.
9. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998; 39: 1529-42.
10. Aslan M, Kosecik M, Horoz M, Selek S, Celik H, Erel O. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis 2007; 191: 397-402.
11. Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M. Paraoxonase (PON-1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knock out mice. Free Radic Biol Med 2003; 34: 774-84.
12. Mackness MI, Arrol S, Abbott C. Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129-35.
13. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 473-80.
14. Jarvik GP, Rozek LS, Brophy VH et al. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype. Arterioscler Thromb Vasc Biol 2000; 20: 2441-7
15. Sarandol A, Sarandol E, Eker SS et al. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1103-8.
16. Ayub A, Mackness MI, Arrol S, Mackness B, Patel J, Durrington PN. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999; 19: 330-5.
17. Romero FJ, Morell B, Romero MJ et al. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect 1998; 106: 1229-34.
18. Isik A, Koca SS, Ustundag B, Celik H, Yildirim A. Paraoxonase and arylesterase levels in rheumatoid arthritis. Clin Rheumatol 2007; 26: 342-8.
19. Gorog P, Kotak DC, Kovacs IB. Simple and specific test for measuring lipid peroxides in plasma. J Clin Pathol 1991; 44: 765-7
20. Djordjevic A, Spasic S, Jovanovic-Galovic A, Djordjevic A, Grubor-Lajsic G. Oxidative stress in diabetic pregnancy: SOD, CAT and GSH-Px activity and lipid peroxidation products. J Matern Fetal Neonatal Med 2004; 16: 367-72.
21. Gupta P, Narang M, Banerjee BD, Basu S. Oxidative stress in term small for gestational age neonates born to undernourished mothers; a case control study. BMC Pediatr 2004; 4: 14.
22. Jenkins C, Wilson R, Roberts J, Miller H, McKillop JH, Walker JJ. Antioxidants. their role in pregnancy and miscarriage. Antioxid Redox Signal 2000; 2: 623-8.
23. Verit FF, Erel O, Sav M, Celik N, Cadirci D. Oxidative stress is associated with clinical severity of nausea and vomiting of pregnancy. Am J Perinatol 2007; 24: 545-8.
24. Lawlor DA, Gaunt TR, Hinks LJ et al. The association of the PON-1 Q192R polymorphism with complications and outcomes of pregnancy: findings from the British Women's Heart and Health cohort study. Paediatr Perinat Epidemiol 2006; 20: 244-50.
25. Kumru S, Aydin S, Gursu MF, Ozcan Z. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women. Eur J Obstet Gynecol Reprod Biol 2004; 114: 177-81.
26. Abramson JL, Hooper WC, Jones DP et al. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis 2005; 178: 115-21.
27. -/- mice: Implications for iNOS and reactive oxygen species. Atherosclerosis 2007; 195: E76-84.
28. Ueland T, Vissers MN, Wiegman A et al. Increased inflammatory markers in children with familial hypercholesterolaemia. Eur J Clin Invest 2006; 36: 147-52.
29. Ridker PM, Cook NR, Lee IM et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352: 1293-304.
30. Smirnakis KV, Plati A, Wolf M, Thadhani R, Ecker JL. Predicting gestational diabetes: Choosing the optimal early serum marker. Am J Obstet Gynecol 2007; 196: 410.e1-6
31. Kumru S, Godekmerdan A, Kutlu S, Ozcan Z. Correlation of maternal serum high-sensitive C-reactive protein levels with biochemical and clinical parameters in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006; 124: 164-7.
32. Järnfelt-Samsioe A, Eriksson B, Mattsson LA, Samsioe G. Serum lipids and lipoproteins in pregnancies associated with emesis gravidarum. Gynecol Endocrinol 1987; 1: 51-60.
33. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31: 1274-82.
34. Turrentine MA, Smalling RW, Parisi VM. Right atrial thrombus as a complication of total parenteral nutrition in pregnancy. Obstet Gynecol 1994; 84: 675-7.